Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stryker Corporation (DE:SYK)
FRANKFURT:SYK
Holding DE:SYK?
Track your performance easily
SYK Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€240.10 - €335.40
Previous Close€333.3
Volume40.00
Average Volume (3M)142.00
Market Cap
€127.37B
Enterprise Value€136.71B
Total Cash (Recent Filing)$1.87B
Total Debt (Recent Filing)$12.22B
Price to Earnings (P/E)40.2
Beta0.55
Next Earnings
Oct 31, 2024EPS Estimate
€2.5Next Dividend Ex-Date
Sep 30, 2024Dividend Yield0.85%
Share Statistics
EPS (TTM)8.30
Shares Outstanding381,075,364
10 Day Avg. Volume76
30 Day Avg. Volume142
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)6.43
Price to Sales (P/S)6.60
Price to Cash Flow (P/CF)55.70
P/FCF Ratio73.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.39
Enterprise Value/Gross Profit10.47
Enterprise Value/Ebitda25.32
Forecast
1Y Price Target
€341.98Price Target Upside2.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
Stryker News
PremiumPress Releases
Stryker completes acquisition of care.ai
Bulls Say, Bears Say
Bulls Say
AcquisitionStryker Corp's acquisition of Vertos Medical significantly enhances its market position by adding a minimally invasive solution for treating chronic lower back pain.
Product ApprovalThe FDA approved SYK's LIFEPAK 35 automated external defibrillator, enhancing its Medical division with advanced connected capabilities.
Technological AdvancementSYK will be launching a comprehensive spine robotic ecosystem with Mako spine, Q Guidance, and CoPilot, providing advanced surgical precision and safety.
Bears Say
Financial PerformanceWe are now modeling Q2 Hips and Knees revenue growth of 8.0%, down from 9.5% and 10.7%, respectively.
Revenue GrowthThis was only the second time in the past seven quarters SYK's global organic revenue growth didn't touch double-digits.
ValuationStock currently trading at 26x forward EPS, indicating it is fully reflected in current valuation and thus remain at Hold.
---
Options Prices
Currently, No data available
---
Ownership Overview
24.88% Insiders
22.78% Mutual Funds
39.69% Other Institutional Investors
12.65% Public Companies and
Individual Investors
SYK FAQ
What was Stryker Corporation’s price range in the past 12 months?
Stryker Corporation lowest stock price was €240.10 and its highest was €335.40 in the past 12 months.
What is Stryker Corporation’s market cap?
Currently, no data Available
When is Stryker Corporation’s upcoming earnings report date?
Stryker Corporation’s upcoming earnings report date is Oct 31, 2024 which is in 41 days.
How were Stryker Corporation’s earnings last quarter?
Stryker Corporation released its earnings results on Jul 30, 2024. The company reported €2.534 earnings per share for the quarter, beating the consensus estimate of €2.518 by €0.016.
Is Stryker Corporation overvalued?
According to Wall Street analysts Stryker Corporation’s price is currently Undervalued.
Does Stryker Corporation pay dividends?
Stryker Corporation pays a Quarterly dividend of €0.72 which represents an annual dividend yield of 0.85%. See more information on Stryker Corporation dividends here
What is Stryker Corporation’s EPS estimate?
Stryker Corporation’s EPS estimate is €2.5.
How many shares outstanding does Stryker Corporation have?
Stryker Corporation has 381,075,380 shares outstanding.
What happened to Stryker Corporation’s price movement after its last earnings report?
Stryker Corporation reported an EPS of €2.534 in its last earnings report, beating expectations of €2.518. Following the earnings report the stock price went down -1.01%.
Which hedge fund is a major shareholder of Stryker Corporation?
Among the largest hedge funds holding Stryker Corporation’s share is Fisher Asset Management LLC. It holds Stryker Corporation’s shares valued at 1B.
---
Stryker Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€341.98 (2.60% Upside)
€341.98 (2.60% Upside)
Blogger Sentiment
Bullish
DE:SYK Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $68.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.34%
12-Months-Change
Fundamentals
Return on Equity
18.58%
Trailing 12-Months
Asset Growth
4.60%
Trailing 12-Months
Company Description
Stryker Corporation
Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.
---
SYK Earnings Call
Q2 2024
0:00 / 0:00
---
SYK Net sales Breakdown
57.74% MedSurg and Neurotechnology
42.26% Orthopaedics and Spine
---
SYK Stock 12 Month Forecast
Average Price Target
€341.98
▲(2.60% Upside)
Technical Analysis
Stryker
―
Becton Dickinson
―
Edwards Lifesciences
―
Zimmer Biomet Holdings
―
Intuitive Surgical
―
Best Analysts Covering SYK
1 Year
1 Year Success Rate
22/25 ratings generated profit
1 Year Average Return
+17.95%
reiterated a buy rating 2 months ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 88.00% of your transactions generating a profit, with an average return of +17.95% per trade.
---